DaVita (DVA) Stock: Buy, Sell, or Hold?
DVA - DaVita Inc.
$193.86
2.96 (1.55%)
▲
5d:
+5.93%
30d:
+9.71%
90d:
-7.24%
WAIT
LOW Confidence
Analysis Updated: Sep 16, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When DVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: DVA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: DVA shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$289.13
Based on 10.1% avg growth
INTRINSIC VALUE TODAY
$179.53
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 10.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DVA is currently trading at $193.86, which is considered extended relative to its 30-day fair value range of $175.94 to $185.16. The stock's valuation (Forward PE: 11.2) is in line with its historical norms (10.4). At these levels, the market is pricing in 2.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DVA is showing sideways momentum. The price is approaching resistance at $195.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $219.86 (+13.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DVA is showing sideways momentum. The price is approaching resistance at $195.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $219.86 (+13.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$175.94 -
$185.16
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.2%
Protect Your Profits
Holding DVA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($219.86)
- NEUTRAL: Market pricing in 2.7% annual earnings growth - fairly valued
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$175.94 -
$185.16
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$8.14
(4.2%)
Support & Resistance Levels
Support Level
$176.43
Resistance Level
$195.07
Current Trend
Sideways
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.24
Wall Street Target
$219.86
(+13.4%)
Revenue Growth (YoY)
5.2%
Earnings Growth (YoY)
55.8%
Profit Margin
6.0%
Valuation Premium vs History
+2.7% premium
PE vs Historical
11.2 vs 10.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.7%
(market-implied from PE analysis)
1-Year Target
$199.09
(+3%)
2-Year Target
$204.47
(+6%)
3-Year Target
$209.99
(+8%)
3-Yr Target (if PE normalizes)
(PE: 11→10)
PE COMPRESSION
$194.33
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 16.2%)
$546.47
(+182%)
Base:
(SPY PE: 11.2, Growth: 16.2%)
$304.17
(+57%)
Bear:
(PE: 9.6, Growth: 16.2%)
$258.55
(+33%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (16x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 16.19 | Current EPS (TTM): $11.79
Bull Case
$307.24
(+59%)
Analyst growth 46.3%, PE expands to 17.8
Base Case
$279.31
(+44%)
Market implied 46.3%, PE stable at 16.2
Bear Case
$129.81
(-33%)
Severe decline -20.0%, PE contracts to 13.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 17, 2026 12:45 AM ET
Data refreshes hourly during market hours. Next update: 1:45 AM
Data refreshes hourly during market hours. Next update: 1:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
DVA is a key holding in these high-performance investment strategies.
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 52 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 58 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 44 HOLD |
Advanced DVA Option Strategies
Professional options setups generated by AI based on today's DVA price and gamma walls.
